Certain New Chemicals or Significant New Uses; Statements of Findings for December 2021, 4229-4230 [2022-01647]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
discriminatory or preferential. PJM
Interconnection, L.L.C., 178 FERC
¶ 61,021 (2022).
The refund effective date in Docket
No. EL22–22–000, established pursuant
to section 206(b) of the FPA, will be the
date of publication of this notice in the
Federal Register.
Any interested person desiring to be
heard in Docket No. EL22–22–000 must
file a notice of intervention or motion to
intervene, as appropriate, with the
Federal Energy Regulatory Commission,
in accordance with Rule 214 of the
Commission’s Rules of Practice and
Procedure, 18 CFR 385.214 (2021),
within 21 days of the date of issuance
of the order.
In addition to publishing the full text
of this document in the Federal
Register, the Commission provides all
interested persons an opportunity to
view and/or print the contents of this
document via the internet through the
Commission’s Home Page (https://
www.ferc.gov) using the ‘‘eLibrary’’ link.
Enter the docket number excluding the
last three digits in the docket number
field to access the document. At this
time, the Commission has suspended
access to the Commission’s Public
Reference Room, due to the
proclamation declaring a National
Emergency concerning the Novel
Coronavirus Disease (COVID–19), issued
by the President on March 13, 2020. For
assistance, contact FERC at
FERCOnlineSupport@ferc.gov or call
toll-free, (886) 208–3676 or TYY, (202)
502–8659.
The Commission strongly encourages
electronic filings of comments, protests
and interventions in lieu of paper using
the ‘‘eFile’’ link at https://www.ferc.gov.
In lieu of electronic filing, you may
submit a paper copy. Submissions sent
via the U.S. Postal Service must be
addressed to: Kimberly D. Bose,
Secretary, Federal Energy Regulatory
Commission, 888 First Street NE, Room
1A, Washington, DC 20426.
Submissions sent via any other carrier
must be addressed to: Kimberly D. Bose,
Secretary, Federal Energy Regulatory
Commission, 12225 Wilkins Avenue,
Rockville, Maryland 20852.
Dated: January 21, 2022.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2022–01636 Filed 1–26–22; 8:45 am]
BILLING CODE 6717–01–P
VerDate Sep<11>2014
17:53 Jan 26, 2022
Jkt 256001
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2021–0146; FRL–8682–09–
OCSPP]
Certain New Chemicals or Significant
New Uses; Statements of Findings for
December 2021
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Toxic Substances Control
Act (TSCA) requires the Environmental
Protection Agency (EPA) to publish in
the Federal Register a statement of its
findings after its review of certain TSCA
notices when EPA makes a finding that
a new chemical substance or significant
new use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to premanufacture notices (PMNs),
microbial commercial activity notices
(MCANs), and significant new use
notices (SNUNs) submitted to EPA
under TSCA. This document presents
statements of findings made by EPA on
such submissions during the period
from December 1, 2021 to December 31,
2021.
FOR FURTHER INFORMATION CONTACT: For
technical information contact: Rebecca
Edelstein, Chemical Control Division
(7405M), Office of Pollution Prevention
and Toxics, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: 202–564–1667 email address:
Edelstein.rebecca@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
4229
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPPT
Docket is (202) 566–0280.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
opened to visitors by appointment only.
For the latest status information on
EPA/DC services and docket access,
visit https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of
findings made by EPA after review of
notices submitted under TSCA section
5(a) that certain new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment. This document presents
statements of findings made by EPA
during the period from December 1,
2021 to December 31, 2021.
III. What is the Agency’s authority for
taking this action?
TSCA section 5(a)(3) requires EPA to
review a TSCA section 5(a) notice and
make one of the following specific
findings:
Æ The chemical substance or
significant new use presents an
unreasonable risk of injury to health or
the environment;
Æ The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects of the chemical
substance or significant new use;
Æ The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects and the chemical
I. General Information
substance or significant new use may
A. Does this action apply to me?
present an unreasonable risk of injury to
This action is directed to the public
health or the environment;
Æ The chemical substance is or will
in general. As such, the Agency has not
be produced in substantial quantities,
attempted to describe the specific
and such substance either enters or may
entities that this action may apply to.
reasonably be anticipated to enter the
Although others may be affected, this
action applies directly to the submitters environment in substantial quantities or
there is or may be significant or
of the PMNs addressed in this action.
substantial human exposure to the
B. How can I get copies of this document
substance; or
and other related information?
Æ The chemical substance or
The docket for this action, identified
significant new use is not likely to
by docket identification (ID) number
present an unreasonable risk of injury to
EPA–HQ–OPPT–2021–0146, is available health or the environment.
Unreasonable risk findings must be
online at https://www.regulations.gov or
at the Office of Pollution Prevention and made without consideration of costs or
other non-risk factors, including an
Toxics Docket (OPPT Docket),
unreasonable risk to a potentially
Environmental Protection Agency
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\27JAN1.SGM
27JAN1
4230
Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices
exposed or susceptible subpopulation
identified as relevant under the
conditions of use. The term ‘‘conditions
of use’’ is defined in TSCA section 3 to
mean ‘‘the circumstances, as determined
by the Administrator, under which a
chemical substance is intended, known,
or reasonably foreseen to be
manufactured, processed, distributed in
commerce, used, or disposed of.’’
EPA is required under TSCA section
5(g) to publish in the Federal Register
a statement of its findings after its
review of a TSCA section 5(a) notice
when EPA makes a finding that a new
chemical substance or significant new
use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to PMNs, MCANs, and SNUNs
submitted to EPA under TSCA section
5.
Anyone who plans to manufacture
(which includes import) a new chemical
EPA case No.
P–18–0348 .........
P–20–0018; P–
20–0019; P–
20–0020; P–
20–0021.
P–21–0120 .........
P–21–0135 .........
P–21–0186; P–
21–0187.
substance for a non-exempt commercial
purpose and any manufacturer or
processor wishing to engage in a use of
a chemical substance designated by EPA
as a significant new use must submit a
notice to EPA at least 90 days before
commencing manufacture of the new
chemical substance or before engaging
in the significant new use.
The submitter of a notice to EPA for
which EPA has made a finding of ‘‘not
likely to present an unreasonable risk of
injury to health or the environment’’
may commence manufacture of the
chemical substance or manufacture or
processing for the significant new use
notwithstanding any remaining portion
of the applicable review period.
IV. What are the statements of
administrator Findings under TSCA
section 5(a)(3)(C)?
In this unit, EPA provides the
following information (to the extent that
Chemical identity
Website link
Ethanol, 2,2’-[1,4-phenylenebis(oxy)]bis-, polymer with 1,6diisocyanatohexane and .alpha.-hydro-.omega.-hydroxypoly(oxy1,4-butanediyl) (specific).
P–20–0018, P–20–0019, P–20–0020: Fatty acid dimers, polymers
with glycerol and triglycerides (generic) P–20–0021: Fatty acid
dimers, polymers with glycerol and fatty acids (generic).
https://www.epa.gov/system/files/documents/2022-01/
p-18-0348_determination_non-cbi_final.pdf.
2-Alkenoic acid, 2-alkyl-, 2-hydroxyalkyl ester, homopolymer, ester
with N-[3-[(carboxyamino)alkyl]-3,5,5- trialkylcycloalkyl]carbamic
acid mono [2-(2-alkoxyethoxy)alkyl] ester, N-[3[(carboxyamino)alkyl]-3,5,5- trialkylcycloalkyl] carbamic acid mono
[2-(dialkylamino) alkyl] ester and 2-oxepanone polymer with
tetrahydro- 2H-pyran-2-one 2-alkylhexyl ester N-[3(carboxyamino)alkyl phenyl] carbamate, 1,1-dialkylpropyl 2alkylhexaneperoxoate—initiated (generic).
Alkenoic acid, allyl-, (dialkylamino)alkyl ester, polymer with dialkyl-alkylene-alkanediyl)bis[carbomoncycle], alkylalkyl alkyl-alkenoate
and alkanediol mono(2-alkyl-alkenoate), diazenediyl)bis[2alkylalkanenitrile]-initiated, (generic).
glycerin, alkoxylated alkyl acid esters (generic) ...................................
https://www.epa.gov/system/files/documents/2022-01/
p-21-0120_determination_non-cbi_final.pdf.
Authority: 15 U.S.C. 2601 et seq.
Dated: January 24, 2022.
Madison Le,
Director, New Chemicals Division, Office of
Pollution Prevention and Toxics.
[FR Doc. 2022–01647 Filed 1–26–22; 8:45 am]
BILLING CODE 6560–50–P
https://www.epa.gov/system/files/documents/2022-01/
p-20-0018-0021_determination_non-cbi_final.pdf.
https://www.epa.gov/system/files/documents/2022-01/
p-21-0135_determination_non-cbi_final.pdf.
https://www.epa.gov/system/files/documents/2022-01/
p-21-0186-0187_determination_non-cbi_final.pdf.
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OAR–2020–0660; FRL–9507–01–
OMS]
Information Collection Request
Submitted to OMB for Review and
Approval; Comment Request; NSPS
for Nonmetallic Mineral Processing
(Renewal)
Environmental Protection
Agency (EPA).
ACTION: Notice.
lotter on DSK11XQN23PROD with NOTICES1
AGENCY:
The Environmental Protection
Agency (EPA) has submitted an
information collection request (ICR),
NSPS for Nonmetallic Mineral
Processing (EPA ICR Number 1084.15,
OMB Control Number 2060–0050), to
the Office of Management and Budget
SUMMARY:
VerDate Sep<11>2014
such information is not claimed as
Confidential Business Information
(CBI)) on the PMNs, MCANs and
SNUNs for which, during this period,
EPA has made findings under TSCA
section 5(a)(3)(C) that the new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment:
Æ EPA case number assigned to the
TSCA section 5(a) notice.
Æ Chemical identity (generic name if
the specific name is claimed as CBI).
Æ Website link to EPA’s decision
document describing the basis of the
‘‘not likely to present an unreasonable
risk’’ finding made by EPA under TSCA
section 5(a)(3)(C).
18:59 Jan 26, 2022
Jkt 256001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act. This is a proposed
extension of the ICR, which is currentlyapproved through March 31, 2022.
Public comments were previously
requested, via the Federal Register, on
February 8, 2021 during a 60-day
comment period. This notice allows for
an additional 30 days for public
comments. A fuller description of the
ICR is given below, including its
estimated burden and cost to the public.
An agency may neither conduct nor
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
DATES: Additional comments may be
submitted on or before February 28,
2022.
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 87, Number 18 (Thursday, January 27, 2022)]
[Notices]
[Pages 4229-4230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01647]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2021-0146; FRL-8682-09-OCSPP]
Certain New Chemicals or Significant New Uses; Statements of
Findings for December 2021
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Toxic Substances Control Act (TSCA) requires the
Environmental Protection Agency (EPA) to publish in the Federal
Register a statement of its findings after its review of certain TSCA
notices when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to
premanufacture notices (PMNs), microbial commercial activity notices
(MCANs), and significant new use notices (SNUNs) submitted to EPA under
TSCA. This document presents statements of findings made by EPA on such
submissions during the period from December 1, 2021 to December 31,
2021.
FOR FURTHER INFORMATION CONTACT: For technical information contact:
Rebecca Edelstein, Chemical Control Division (7405M), Office of
Pollution Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: 202-
564-1667 email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. As such, the
Agency has not attempted to describe the specific entities that this
action may apply to. Although others may be affected, this action
applies directly to the submitters of the PMNs addressed in this
action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPPT-2021-0146, is available online at https://www.regulations.gov or at the Office of Pollution Prevention and Toxics
Docket (OPPT Docket), Environmental Protection Agency Docket Center
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is opened to visitors by
appointment only. For the latest status information on EPA/DC services
and docket access, visit https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of findings made by EPA after
review of notices submitted under TSCA section 5(a) that certain new
chemical substances or significant new uses are not likely to present
an unreasonable risk of injury to health or the environment. This
document presents statements of findings made by EPA during the period
from December 1, 2021 to December 31, 2021.
III. What is the Agency's authority for taking this action?
TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a)
notice and make one of the following specific findings:
[cir] The chemical substance or significant new use presents an
unreasonable risk of injury to health or the environment;
[cir] The information available to EPA is insufficient to permit a
reasoned evaluation of the health and environmental effects of the
chemical substance or significant new use;
[cir] The information available to EPA is insufficient to permit a
reasoned evaluation of the health and environmental effects and the
chemical substance or significant new use may present an unreasonable
risk of injury to health or the environment;
[cir] The chemical substance is or will be produced in substantial
quantities, and such substance either enters or may reasonably be
anticipated to enter the environment in substantial quantities or there
is or may be significant or substantial human exposure to the
substance; or
[cir] The chemical substance or significant new use is not likely
to present an unreasonable risk of injury to health or the environment.
Unreasonable risk findings must be made without consideration of
costs or other non-risk factors, including an unreasonable risk to a
potentially
[[Page 4230]]
exposed or susceptible subpopulation identified as relevant under the
conditions of use. The term ``conditions of use'' is defined in TSCA
section 3 to mean ``the circumstances, as determined by the
Administrator, under which a chemical substance is intended, known, or
reasonably foreseen to be manufactured, processed, distributed in
commerce, used, or disposed of.''
EPA is required under TSCA section 5(g) to publish in the Federal
Register a statement of its findings after its review of a TSCA section
5(a) notice when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to PMNs,
MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture (which includes import) a new
chemical substance for a non-exempt commercial purpose and any
manufacturer or processor wishing to engage in a use of a chemical
substance designated by EPA as a significant new use must submit a
notice to EPA at least 90 days before commencing manufacture of the new
chemical substance or before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding
of ``not likely to present an unreasonable risk of injury to health or
the environment'' may commence manufacture of the chemical substance or
manufacture or processing for the significant new use notwithstanding
any remaining portion of the applicable review period.
IV. What are the statements of administrator Findings under TSCA
section 5(a)(3)(C)?
In this unit, EPA provides the following information (to the extent
that such information is not claimed as Confidential Business
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this
period, EPA has made findings under TSCA section 5(a)(3)(C) that the
new chemical substances or significant new uses are not likely to
present an unreasonable risk of injury to health or the environment:
[cir] EPA case number assigned to the TSCA section 5(a) notice.
[cir] Chemical identity (generic name if the specific name is
claimed as CBI).
[cir] Website link to EPA's decision document describing the basis
of the ``not likely to present an unreasonable risk'' finding made by
EPA under TSCA section 5(a)(3)(C).
----------------------------------------------------------------------------------------------------------------
EPA case No. Chemical identity Website link
----------------------------------------------------------------------------------------------------------------
P-18-0348......................... Ethanol, 2,2'-[1,4-phenylenebis(oxy)]bis- https://www.epa.gov/system/files/
, polymer with 1,6-diisocyanatohexane documents/2022-01/p-18-
and .alpha.-hydro-.omega.- 0348_determination_non-
hydroxypoly(oxy-1,4-butanediyl) cbi_final.pdf.
(specific).
P-20-0018; P-20-0019; P-20-0020; P- P-20-0018, P-20-0019, P-20-0020: Fatty https://www.epa.gov/system/files/
20-0021. acid dimers, polymers with glycerol and documents/2022-01/p-20-0018-
triglycerides (generic) P-20-0021: Fatty 0021_determination_non-
acid dimers, polymers with glycerol and cbi_final.pdf.
fatty acids (generic).
P-21-0120......................... 2-Alkenoic acid, 2-alkyl-, 2-hydroxyalkyl https://www.epa.gov/system/files/
ester, homopolymer, ester with N-[3- documents/2022-01/p-21-
[(carboxyamino)alkyl]-3,5,5- 0120_determination_non-
trialkylcycloalkyl]carbamic acid mono [2- cbi_final.pdf.
(2-alkoxyethoxy)alkyl] ester, N-[3-
[(carboxyamino)alkyl]-3,5,5-
trialkylcycloalkyl] carbamic acid mono
[2-(dialkylamino) alkyl] ester and 2-
oxepanone polymer with tetrahydro- 2H-
pyran-2-one 2-alkylhexyl ester N-[3-
(carboxyamino)alkyl phenyl] carbamate,
1,1-dialkylpropyl 2-
alkylhexaneperoxoate--initiated
(generic).
P-21-0135......................... Alkenoic acid, allyl-, https://www.epa.gov/system/files/
(dialkylamino)alkyl ester, polymer with documents/2022-01/p-21-
dialkyl-alkylene- 0135_determination_non-
alkanediyl)bis[carbomoncycle], cbi_final.pdf.
alkylalkyl alkyl-alkenoate and
alkanediol mono(2-alkyl-alkenoate),
diazenediyl)bis[2-alkylalkanenitrile]-
initiated, (generic).
P-21-0186; P-21-0187.............. glycerin, alkoxylated alkyl acid esters https://www.epa.gov/system/files/
(generic). documents/2022-01/p-21-0186-
0187_determination_non-
cbi_final.pdf.
----------------------------------------------------------------------------------------------------------------
Authority: 15 U.S.C. 2601 et seq.
Dated: January 24, 2022.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2022-01647 Filed 1-26-22; 8:45 am]
BILLING CODE 6560-50-P
